600488 津药药业
交易中 08-28 09:36:47
资讯
新帖
简况
津药药业（600488）2026年中报简析：净利润同比下降12.43%
证券之星 · 08-27 06:04
津药药业（600488）2026年中报简析：净利润同比下降12.43%
图解津药药业中报：第二季度单季净利润同比增长434.81%
证券之星 · 08-26 01:38
图解津药药业中报：第二季度单季净利润同比增长434.81%
津药药业（600488）披露2026年半年度报告，8月25日股价上涨5.42%
证券之星 · 08-25 22:20
津药药业（600488）披露2026年半年度报告，8月25日股价上涨5.42%
股市必读：津药药业（600488）8月24日收盘跌6.17%，主力净流出1467.34万元
证券之星 · 08-25
股市必读：津药药业（600488）8月24日收盘跌6.17%，主力净流出1467.34万元
股市必读：津药药业新发布《津药药业股份有限公司关于子公司小儿复方氨基酸注射液（18AA-I）获得缅甸卫生部药品注册证书的公告》
证券之星 · 08-19
股市必读：津药药业新发布《津药药业股份有限公司关于子公司小儿复方氨基酸注射液（18AA-I）获得缅甸卫生部药品注册证书的公告》
津药药业(600488.SH)：小儿复方氨基酸注射液(18AA-I)获得缅甸卫生部药品注册证书
智通财经 · 08-17
津药药业(600488.SH)：小儿复方氨基酸注射液(18AA-I)获得缅甸卫生部药品注册证书
股市必读：津药药业新发布《津药药业股份有限公司关于子公司药品新增规格及通过仿制药一致性评价的公告》
证券之星 · 08-17
股市必读：津药药业新发布《津药药业股份有限公司关于子公司药品新增规格及通过仿制药一致性评价的公告》
津药药业(600488.SH)子公司维生素B₆注射液新增规格及通过仿制药一致性评价
智通财经 · 08-14
津药药业(600488.SH)子公司维生素B₆注射液新增规格及通过仿制药一致性评价
津药药业：甾体激素原料药价格总体保持平稳
证券之星 · 08-12
津药药业：甾体激素原料药价格总体保持平稳
津药药业：截至2026年8月10日，公司股东数为110,517户
证券之星 · 08-11
津药药业：截至2026年8月10日，公司股东数为110,517户
每周股票复盘：津药药业（600488）子公司获两项药品注册证书
证券之星 · 08-09
每周股票复盘：津药药业（600488）子公司获两项药品注册证书
津药药业最新公告：子公司氨甲环酸氯化钠注射液获药品注册证书
证券之星 · 08-07
津药药业最新公告：子公司氨甲环酸氯化钠注射液获药品注册证书
股市必读：津药药业新发布《津药药业股份有限公司关于子公司产品在全国药品集中采购中拟中选的公告》
证券之星 · 08-06
股市必读：津药药业新发布《津药药业股份有限公司关于子公司产品在全国药品集中采购中拟中选的公告》
津药药业：截至2026年7月31日，公司股东数为85,254户
证券之星 · 08-04
津药药业：截至2026年7月31日，公司股东数为85,254户
津药药业(600488.SH)子公司复合磷酸氢钾注射剂拟中选第十二批全国药品集中采购
智通财经 · 08-04
津药药业(600488.SH)子公司复合磷酸氢钾注射剂拟中选第十二批全国药品集中采购
津药药业(600488.SH)子公司获得复方电解质注射液药品注册证书
智通财经 · 08-03
津药药业(600488.SH)子公司获得复方电解质注射液药品注册证书
异动快报：津药药业（600488）7月27日9点43分触及涨停板
证券之星 · 07-27
异动快报：津药药业（600488）7月27日9点43分触及涨停板
每周股票复盘：津药药业（600488）三日跌幅偏离值累计达20%
证券之星 · 07-26
每周股票复盘：津药药业（600488）三日跌幅偏离值累计达20%
异动快报：津药药业（600488）7月21日10点9分触及跌停板
证券之星 · 07-21
异动快报：津药药业（600488）7月21日10点9分触及跌停板
股市必读：津药药业（600488）7月17日收盘跌停，主力净流出1596.6万元
证券之星 · 07-20
股市必读：津药药业（600488）7月17日收盘跌停，主力净流出1596.6万元
加载更多
公司概况
公司名称：
津药药业股份有限公司
所属行业：
医药制造业
上市日期：
2001-06-18
主营业务：
津药药业股份有限公司的主营业务是甾体激素类、氨基酸类原料药及制剂的研发、生产和销售。公司的主要产品是甾体激素类、氨基酸类、制剂。
发行价格：
11.25
{"stockData":{"symbol":"600488","market":"SH","secType":"STK","nameCN":"津药药业","latestPrice":5.57,"timestamp":1787881007000,"preClose":5.7,"halted":0,"volume":15732900,"delay":0,"changeRate":-0.0228,"floatShares":1092000000,"shares":1092000000,"eps":0.0591,"marketStatus":"交易中","change":-0.13,"latestTime":"08-28 09:36:47","open":5.7,"high":5.75,"low":5.55,"amount":88305300,"amplitude":0.0351,"askPrice":5.58,"askSize":92,"bidPrice":5.57,"bidSize":1312,"shortable":0,"etf":0,"ttmEps":0.0591,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1787887800000},"marketStatusCode":2,"adr":0,"adjPreClose":5.7,"symbolType":"stock","openAndCloseTimeList":[[1787880600000,1787887800000],[1787893200000,1787900400000]],"highLimit":6.27,"lowLimit":5.13,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1091886680,"isCdr":false,"pbRate":2.06,"roa":"--","peRate":94.247039,"roe":"1.41%","epsLYR":0.065,"committee":0.602917,"marketValue":6082000000,"turnoverRate":0.0144,"status":1,"floatMarketCap":6082000000},"requestUrl":"/m/hq/s/600488","defaultTab":"news","newsList":[{"id":"2662989740","title":"津药药业（600488）2026年中报简析：净利润同比下降12.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662989740","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662989740?lang=zh_cn&edition=full","pubTime":"2026-08-27 06:04","pubTimestamp":1787781898,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期津药药业发布2026年中报。根据财报显示，津药药业净利润同比下降12.43%。截至本报告期末，公司营业总收入13.13亿元，同比下降17.33%，归母净利润4317.35万元，同比下降12.43%。按单季度数据看，第二季度营业总收入7.05亿元，同比下降12.17%，第二季度归母净利润2928.22万元，同比上升434.81%。去年的净利率为4.2%，算上全部成本后，公司产品或服务的附加值不高。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700010894.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600488"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662759164","title":"图解津药药业中报：第二季度单季净利润同比增长434.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662759164","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662759164?lang=zh_cn&edition=full","pubTime":"2026-08-26 01:38","pubTimestamp":1787679498,"startTime":"0","endTime":"0","summary":"证券之星消息，津药药业2026年中报显示，上半年度公司主营收入13.13亿元，同比下降17.33%；归母净利润4317.35万元，同比下降12.43%；扣非净利润4286.81万元，同比下降63.24%；其中2026年第二季度，公司单季度主营收入7.05亿元，同比下降12.17%；单季度归母净利润2928.22万元，同比上升434.81%；单季度扣非净利润2890.06万元，同比下降51.24%；负债率33.13%，投资收益-8.65万元，财务费用1611.49万元，毛利率41.47%。财报数据概要请见下图:本文数据来源于津药药业2026年中报，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082600004215.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600488"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662758772","title":"津药药业（600488）披露2026年半年度报告，8月25日股价上涨5.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662758772","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662758772?lang=zh_cn&edition=full","pubTime":"2026-08-25 22:20","pubTimestamp":1787667651,"startTime":"0","endTime":"0","summary":"截至2026年8月25日收盘，津药药业报收于5.45元，较前一交易日上涨5.42%，最新总市值为59.51亿元。该股当日开盘5.16元，最高5.55元，最低5.07元，成交额达3.77亿元，换手率为6.47%。近日，津药药业股份有限公司披露《2026年半年度报告》。公告显示，公司总资产为5,749,485,621.65元，较上年度末减少0.18%；归属于上市公司股东的净资产为3,023,768,744.19元，较上年度末减少0.35%。经营活动产生的现金流量净额为191,778,302.86元，同比上升849.37%。公司董事会审议通过本报告，未提出利润分配预案。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082500050673.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600488","BK0102","BK0239","BK0028","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662208680","title":"股市必读：津药药业（600488）8月24日收盘跌6.17%，主力净流出1467.34万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2662208680","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662208680?lang=zh_cn&edition=full","pubTime":"2026-08-25 01:05","pubTimestamp":1787591114,"startTime":"0","endTime":"0","summary":"截至2026年8月24日收盘，津药药业报收于5.17元，下跌6.17%，换手率5.33%，成交量58.23万手，成交额3.06亿元。交易信息汇总股价提醒8月24日津药药业收盘报5.17元，跌6.17%，当日成交3.06亿元。资金流向8月24日主力资金净流出1467.34万元，占总成交额4.8%；游资资金净流出2326.0万元，占总成交额7.6%；散户资金净流入3793.34万元，占总成交额12.4%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082500002877.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0102","BK0028","BK0239","600488"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660499327","title":"股市必读：津药药业新发布《津药药业股份有限公司关于子公司小儿复方氨基酸注射液（18AA-I）获得缅甸卫生部药品注册证书的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2660499327","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660499327?lang=zh_cn&edition=full","pubTime":"2026-08-19 01:01","pubTimestamp":1787072475,"startTime":"0","endTime":"0","summary":"截至2026年8月18日收盘，津药药业报收于6.15元，上涨2.16%，换手率7.96%，成交量86.91万手，成交额5.29亿元。当日关注点交易信息汇总：8月18日主力资金净流入2659.22万元，占总成交额5.03%。该药品为肠外营养类处方药，适用于小儿消化系统疾病无法进食、低蛋白血症等情况。2023年提交注册申请，近期获批。2024年和2025年该药品在国内销售额分别为2.06亿元和1.46亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081900001124.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600488","BK0102","BK0239","BK0028","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660488664","title":"津药药业(600488.SH)：小儿复方氨基酸注射液(18AA-I)获得缅甸卫生部药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2660488664","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660488664?lang=zh_cn&edition=full","pubTime":"2026-08-17 15:44","pubTimestamp":1786952660,"startTime":"0","endTime":"0","summary":"智通财经APP讯，津药药业(600488.SH)发布公告，近日，公司子公司津药和平(天津)制药有限公司(以下简称“津药和平”)小儿复方氨基酸注射液(18AA-I)收到缅甸卫生部药品注册证书(标志着可以生产并在缅甸市场销售该产品)。本次产品顺利取得境外上市资质，为公司制剂板块海外市场开拓筑牢根基、开辟新业务增长空间，更将有力助推国际化发展战略稳步落地。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1480694.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0028","BK0102","600488","BK0012","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660708241","title":"股市必读：津药药业新发布《津药药业股份有限公司关于子公司药品新增规格及通过仿制药一致性评价的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2660708241","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660708241?lang=zh_cn&edition=full","pubTime":"2026-08-17 01:21","pubTimestamp":1786900868,"startTime":"0","endTime":"0","summary":"公司公告汇总：津药药业子公司维生素B注射液新增1ml：0.1g规格，并通过仿制药一致性评价，2025年国内销售额3.72亿元。公司公告汇总津药药业股份有限公司关于子公司药品新增规格及通过仿制药一致性评价的公告津药药业子公司湖北津药药业收到国家药品监督管理局核准签发的维生素B注射液《药品补充申请批准通知书》，批准新增1ml：0.1g规格，并通过仿制药质量和疗效一致性评价。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081700000491.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0012","600488","BK0102","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659277119","title":"津药药业(600488.SH)子公司维生素B₆注射液新增规格及通过仿制药一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2659277119","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659277119?lang=zh_cn&edition=full","pubTime":"2026-08-14 15:49","pubTimestamp":1786693743,"startTime":"0","endTime":"0","summary":"智通财经APP讯，津药药业(600488.SH)发布公告，近日，公司子公司湖北津药药业股份有限公司收到国家药品监督管理局核准签发的维生素B₆注射液的《药品补充申请批准通知书》，批准本品新增1ml：0.1g规格及通过仿制药质量和疗效一致性评价(简称“一致性评价”)。该药品适用于维生素B₆缺乏的预防和治疗。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1479987.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0102","BK0012","600488","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658927804","title":"津药药业：甾体激素原料药价格总体保持平稳","url":"https://stock-news.laohu8.com/highlight/detail?id=2658927804","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658927804?lang=zh_cn&edition=full","pubTime":"2026-08-12 15:57","pubTimestamp":1786521427,"startTime":"0","endTime":"0","summary":"证券之星消息，津药药业08月12日在投资者关系平台上答复投资者关心的问题。二季度以及最近两个月，该涨价后自产原料药的新增询价、新签订单落地情况能否介绍.若具体订单数据属于商业机密不便披露，请提示后期关注后续定期报告，感谢津药药业回复：投资者您好！目前，公司生产经营情况正常，甾体激素原料药价格总体保持平稳。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081200024272.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600488","BK0012","BK0239","BK0102","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658996898","title":"津药药业：截至2026年8月10日，公司股东数为110,517户","url":"https://stock-news.laohu8.com/highlight/detail?id=2658996898","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658996898?lang=zh_cn&edition=full","pubTime":"2026-08-11 17:15","pubTimestamp":1786439725,"startTime":"0","endTime":"0","summary":"证券之星消息，津药药业(600488)08月11日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好，请问截止到2026年8月10日，贵司最新股东总户数是多少？感谢回单津药药业回复：投资者您好！截至2026年8月10日，公司股东数为110,517户。感谢您的关注！本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081100027285.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","BK0012","600488","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658673167","title":"每周股票复盘：津药药业（600488）子公司获两项药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2658673167","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658673167?lang=zh_cn&edition=full","pubTime":"2026-08-09 01:38","pubTimestamp":1786210692,"startTime":"0","endTime":"0","summary":"截至2026年8月7日收盘，津药药业报收于5.91元，较上周的5.16元上涨14.53%。津药药业控股子公司津药和平（天津）制药有限公司参加国家组织的第十二批药品集中采购，复合磷酸氢钾注射剂拟中选。津药药业子公司湖北津药收到国家药品监督管理局核准签发的氨甲环酸氯化钠注射液《药品注册证书》。湖北津药已累计投入研发费用约360万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080900000282.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0102","BK0028","BK0239","600488"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657168616","title":"津药药业最新公告：子公司氨甲环酸氯化钠注射液获药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2657168616","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657168616?lang=zh_cn&edition=full","pubTime":"2026-08-07 16:51","pubTimestamp":1786092694,"startTime":"0","endTime":"0","summary":"津药药业(600488.SH)公告称，公司子公司湖北津药收到国家药监局核准签发的氨甲环酸氯化钠注射液《药品注册证书》。该药品主要用于急性或慢性、局限性或全身性原发性纤维蛋白溶解亢进所致的各种出血，按化学药品3类注册申报，获批后视为通过仿制药质量和疗效一致性评价。该药品获批将完善公司制剂产品群，对拓展国内制剂市场、提升业绩带来积极影响。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080700028269.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0239","BK0028","600488","BK0102"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657529719","title":"股市必读：津药药业新发布《津药药业股份有限公司关于子公司产品在全国药品集中采购中拟中选的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2657529719","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657529719?lang=zh_cn&edition=full","pubTime":"2026-08-06 01:04","pubTimestamp":1785949456,"startTime":"0","endTime":"0","summary":"截至2026年8月5日收盘，津药药业报收于5.55元，上涨1.46%，换手率6.38%，成交量69.68万手，成交额3.84亿元。公司公告汇总津药药业股份有限公司关于子公司产品在全国药品集中采购中拟中选的公告津药药业控股子公司津药和平（天津）制药有限公司参加国家组织的第十二批药品集中采购，复合磷酸氢钾注射剂拟中选。该产品2025年销售收入占公司营收0.40%，2026年一季度占比0.15%。拟中选结果尚待最终确认，后续签订采购协议及对公司业绩影响存在不确定性。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080600001274.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0012","BK0102","BK0239","600488"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656539528","title":"津药药业：截至2026年7月31日，公司股东数为85,254户","url":"https://stock-news.laohu8.com/highlight/detail?id=2656539528","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656539528?lang=zh_cn&edition=full","pubTime":"2026-08-04 16:57","pubTimestamp":1785833854,"startTime":"0","endTime":"0","summary":"证券之星消息，津药药业(600488)08月04日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘 你好 衷心感谢你们不厌其烦回答投资者的提问。请问贵公司2026年7月31日A股股东人数是多少？谢谢津药药业回复：投资者您好！截至2026年7月31日，公司股东数为85,254户。感谢您的关注！本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080400027981.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0102","BK0028","BK0239","600488"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656535912","title":"津药药业(600488.SH)子公司复合磷酸氢钾注射剂拟中选第十二批全国药品集中采购","url":"https://stock-news.laohu8.com/highlight/detail?id=2656535912","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656535912?lang=zh_cn&edition=full","pubTime":"2026-08-04 16:09","pubTimestamp":1785830973,"startTime":"0","endTime":"0","summary":"智通财经APP讯，津药药业 发布公告，近日，公司控股子公司津药和平(天津)制药有限公司参加了国家组织药品联合采购办公室组织的第十二批全国药品集中采购，复合磷酸氢钾注射剂拟中选此次集中采购。据悉，上述拟中选产品2025年度销售收入为1148.71万元，占公司2025年度营业收入比例为0.40%;2026年一季度销售收入为91.57万元，占公司2026年一季度营业收入比例为0.15%。此次拟中选产品的中选价格与原销售价格相比有一定程度下降。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1475727.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0012","BK0102","BK0028","600488","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656329381","title":"津药药业(600488.SH)子公司获得复方电解质注射液药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2656329381","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656329381?lang=zh_cn&edition=full","pubTime":"2026-08-03 15:37","pubTimestamp":1785742678,"startTime":"0","endTime":"0","summary":"智通财经APP讯，津药药业(600488.SH)发布公告，近日，公司子公司湖北津药药业股份有限公司收到国家药品监督管理局核准签发的复方电解质注射液的《药品注册证书》。该药品可作为水、电解质的补充源和碱化剂。此次获得药品注册证书，完善了公司制剂产品群，将对公司拓展国内制剂市场、提升公司业绩带来一定的积极影响。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1475219.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"津药药业(600488.SH)子公司获得复方电解质注射液药品注册证书","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0012","BK0102","BK0239","BK0028","600488"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654709320","title":"异动快报：津药药业（600488）7月27日9点43分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2654709320","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654709320?lang=zh_cn&edition=full","pubTime":"2026-07-27 09:46","pubTimestamp":1785116796,"startTime":"0","endTime":"0","summary":"证券之星7月27日盘中消息，9点43分津药药业（600488）触及涨停板。其所属行业化学制药目前上涨。领涨股为永安药业。该股为化学原料药，医药，辅助生殖概念热股，当日化学原料药概念上涨2.76%，医药概念上涨2.58%，辅助生殖概念上涨2.16%。7月24日的资金流向数据方面，主力资金净流出1374.75万元，占总成交额3.28%，游资资金净流出1979.23万元，占总成交额4.73%，散户资金净流入3353.98万元，占总成交额8.01%。近5日资金流向一览见下表：津药药业主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072700004006.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","BK0239","600488","BK0012","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654776052","title":"每周股票复盘：津药药业（600488）三日跌幅偏离值累计达20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2654776052","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654776052?lang=zh_cn&edition=full","pubTime":"2026-07-26 01:57","pubTimestamp":1785002234,"startTime":"0","endTime":"0","summary":"截至2026年7月24日收盘，津药药业报收于4.84元，较上周的5.81元下跌16.7%。本周，津药药业7月20日盘中最高价报5.58元。本周关注点来自交易信息汇总：津药药业因三日收盘价跌幅偏离值累计达20%登上龙虎榜。公司公告汇总津药药业股份有限公司股票交易异常波动公告津药药业股份有限公司股票于2026年7月16日、7月17日、7月20日连续三个交易日内日收盘价格跌幅偏离值累计达到20%，属于股票交易异常波动情形。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072600000463.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600488","BK0012","BK0239","BK0028","BK0102"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653240999","title":"异动快报：津药药业（600488）7月21日10点9分触及跌停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2653240999","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653240999?lang=zh_cn&edition=full","pubTime":"2026-07-21 10:12","pubTimestamp":1784599939,"startTime":"0","endTime":"0","summary":"证券之星7月21日盘中消息，10点9分津药药业（600488）触及跌停板。其所属行业化学制药目前下跌。领涨股为恩华药业。该股为新冠病毒防治，医药，化学原料药概念热股。7月20日的资金流向数据方面，主力资金净流入4510.55万元，占总成交额6.56%，游资资金净流出5095.08万元，占总成交额7.41%，散户资金净流入584.53万元，占总成交额0.85%。近5日资金流向一览见下表：津药药业主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072100013791.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0028","BK0102","BK0239","600488"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652252100","title":"股市必读：津药药业（600488）7月17日收盘跌停，主力净流出1596.6万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2652252100","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652252100?lang=zh_cn&edition=full","pubTime":"2026-07-20 01:18","pubTimestamp":1784481490,"startTime":"0","endTime":"0","summary":"截至2026年7月17日收盘，津药药业报收于5.81元，下跌9.92%，跌停，换手率6.08%，成交量66.44万手，成交额3.97亿元。当日关注点交易信息汇总：津药药业7月17日收盘跌停，报5.81元，当日成交3.97亿元。交易信息汇总：前10个交易日主力资金累计净流入2525.56万元，但股价累计下跌9.92%。资金流向7月17日主力资金净流出1596.6万元；游资资金净流出1846.54万元；散户资金净流入3443.14万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072000000638.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0028","BK0102","600488","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1787881010128,"stockEarnings":[{"period":"1week","weight":-0.0355},{"period":"1month","weight":0.0857},{"period":"3month","weight":0.0377},{"period":"6month","weight":0.3494},{"period":"1year","weight":0.334},{"period":"ytd","weight":0.4057}],"compareEarnings":[{"period":"1week","weight":0.0135},{"period":"1month","weight":0.0376},{"period":"3month","weight":-0.0275},{"period":"6month","weight":-0.0496},{"period":"1year","weight":0.0411},{"period":"ytd","weight":-0.0031}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"津药药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"110517人(较上一季度增加29.63%)","perCapita":"9879股","listingDate":"2001-06-18","address":"天津市东丽区开发区西区新业九街19号","registeredCapital":"109188万元","survey":" 津药药业股份有限公司的主营业务是甾体激素类、氨基酸类原料药及制剂的研发、生产和销售。公司的主要产品是甾体激素类、氨基酸类、制剂。","listedPrice":11.25},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"津药药业(600488)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供津药药业(600488)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"津药药业,600488,津药药业股票,津药药业股票老虎,津药药业股票老虎国际,津药药业行情,津药药业股票行情,津药药业股价,津药药业股市,津药药业股票价格,津药药业股票交易,津药药业股票购买,津药药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"津药药业(600488)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供津药药业(600488)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}